Related references
Note: Only part of the references are listed.Menopausal Hormone Therapy and Risk of Colorectal Cancer
Jill R. Johnson et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2009)
Postmenopausal Levels of Endogenous Sex Hormones and Risk of Colorectal Cancer
Tess V. Clendenen et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2009)
Colorectal Cancer in Relation to Postmenopausal Estrogen and Estrogen Plus Progestin in the Women's Health Initiative Clinical Trial and Observational Study
Ross L. Prentice et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2009)
Use of Hormone Replacement Therapy and the Risk of Colorectal Cancer
Gad Rennert et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Conjugated equine estrogens and colorectal cancer incidence and survival: The women's health initiative randomized clinical trial
Cheryl Ritenbaugh et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2008)
Insulin, insulin-like growth factor-I, endogenous estradiol, and risk of colorectal cancer in postmenopausal women
Marc J. Gunter et al.
CANCER RESEARCH (2008)
Oestrogen and the colon: potential mechanisms for cancer prevention
Rory Kennelly et al.
LANCET ONCOLOGY (2008)
Menopause hormone replacement therapy and cancer risk: an Italian record linkage investigation
G. Corrao et al.
ANNALS OF ONCOLOGY (2008)
Exogenous hormones and colorectal cancer risk in Canada: associations stratified by clinically defined familial risk of cancer
Peter T. Campbell et al.
CANCER CAUSES & CONTROL (2007)
Estrogen plus progestin use, microsatellite instability, and the risk of colorectal cancer in women
Polly A. Newcomb et al.
CANCER RESEARCH (2007)
A simulation using data from a primary care practice database closely replicated the women's health initiative trial
Richard L. Tannen et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2007)
Estrogen affects post-menopausal women differently than estrogen plus progestin replacement therapy
Richard L. Tannen et al.
HUMAN REPRODUCTION (2007)
Colon cancer risk and different HRT formulations:: a case-control study
Juergen C. Dinger et al.
BMC CANCER (2007)
O6-methylguanine-DNA methyltransferase Leu84Phe and Ile143Val polymorphisms and risk of colorectal cancer in the Nurses' Health Study and Physicians' Health Study (United States)
GJ Tranah et al.
CANCER CAUSES & CONTROL (2006)
MGMT promoter methylation and field defect in sporadic colorectal cancer
LL Shen et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2005)
Gene-specific methylation and subsequent risk of colorectal adenomas among participants of the polyp prevention trial
K Woodson et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2005)
Analysis of repetitive element DNA methylation by MethyLight
DJ Weisenberger et al.
NUCLEIC ACIDS RESEARCH (2005)
Effects of conjugated, equine estrogen in postmenopausal women with hysterectomy - The women's health initiative randomized controlled trial
GL Anderson et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2004)
Estrogen plus progestin and colorectal cancer in postmenopausal women
RT Chlebowski et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Association of breast cancer DNA methylation profiles with hormone receptor status and response to tamoxifen
M Widschwendter et al.
CANCER RESEARCH (2004)
The effects of transdermal and oral oestrogen replacement therapy on colorectal cancer risk in postmenopausal women
I Csizmadi et al.
BRITISH JOURNAL OF CANCER (2004)
Distinct methylation profiles of glioma subtypes
K Uhlmann et al.
INTERNATIONAL JOURNAL OF CANCER (2003)
MethyLight: a high-throughput assay to measure DNA methylation
Cindy A. Eads et al.
NUCLEIC ACIDS RESEARCH (2000)
Share Paper
